| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4002508 | American Journal of Ophthalmology | 2014 | 10 Pages |
Abstract
Combination therapy of PDT with intravitreal bevacizumab injections showed favorable visual outcomes, and significant visual improvement was maintained in PCV patients. A total of 88.2% of patients avoided visual loss at 3 years after treatments. Largest polyp size at baseline and location of polypoidal lesions were prognostic factors for long-term visual outcomes in these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Hae Min Kang, Hyoung Jun Koh, Christopher Seungkyu Lee, Sung Chul Lee,